Cite
HARVARD Citation
Wang, Y. et al. (2022). A randomized, double-blind, single-dose, two-way, parallel phase I clinical study comparing the pharmacokinetics and safety of adalimumab injecta and Humira® in healthy Chinese male volunteers. Expert opinion on biological therapy. pp. 225-234. [Online].